These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

469 related articles for article (PubMed ID: 34206629)

  • 21. Gut microbiota-bile acid-intestinal Farnesoid X receptor signaling axis orchestrates cadmium-induced liver injury.
    Liu Y; Kang W; Liu S; Li J; Liu J; Chen X; Gan F; Huang K
    Sci Total Environ; 2022 Nov; 849():157861. PubMed ID: 35934034
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Probiotics Alleviated Nonalcoholic Fatty Liver Disease in High-Fat Diet-Fed Rats via Gut Microbiota/FXR/FGF15 Signaling Pathway.
    Luo M; Yan J; Wu L; Wu J; Chen Z; Jiang J; Chen Z; He B
    J Immunol Res; 2021; 2021():2264737. PubMed ID: 34458376
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nuciferine Protects Against High-Fat Diet-Induced Hepatic Steatosis
    Sun J; Fan J; Li T; Yan X; Jiang Y
    J Agric Food Chem; 2022 Sep; 70(38):12014-12028. PubMed ID: 36106619
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway.
    Sun R; Yang N; Kong B; Cao B; Feng D; Yu X; Ge C; Huang J; Shen J; Wang P; Feng S; Fei F; Guo J; He J; Aa N; Chen Q; Pan Y; Schumacher JD; Yang CS; Guo GL; Aa J; Wang G
    Mol Pharmacol; 2017 Feb; 91(2):110-122. PubMed ID: 27932556
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatic inflammation caused by dysregulated bile acid synthesis is reversible by butyrate supplementation.
    Sheng L; Jena PK; Hu Y; Liu HX; Nagar N; Kalanetra KM; French SW; French SW; Mills DA; Wan YY
    J Pathol; 2017 Dec; 243(4):431-441. PubMed ID: 28892150
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulation of the Gut Microbiota-farnesoid X Receptor Axis Improves Deoxycholic Acid-induced Intestinal Inflammation in Mice.
    Xu M; Shen Y; Cen M; Zhu Y; Cheng F; Tang L; Zheng X; Kim JJ; Dai N; Hu W
    J Crohns Colitis; 2021 Jul; 15(7):1197-1210. PubMed ID: 33417675
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Network Involving Gut Microbiota, Circulating Bile Acids, and Hepatic Metabolism Genes That Protects Against Non-Alcoholic Fatty Liver Disease.
    Petrov PD; García-Mediavilla MV; Guzmán C; Porras D; Nistal E; Martínez-Flórez S; Castell JV; González-Gallego J; Sánchez-Campos S; Jover R
    Mol Nutr Food Res; 2019 Oct; 63(20):e1900487. PubMed ID: 31322321
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SIRT3 Deficiency Promotes High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease in Correlation with Impaired Intestinal Permeability through Gut Microbial Dysbiosis.
    Chen M; Hui S; Lang H; Zhou M; Zhang Y; Kang C; Zeng X; Zhang Q; Yi L; Mi M
    Mol Nutr Food Res; 2019 Feb; 63(4):e1800612. PubMed ID: 30525304
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Beneficial effects of exercise on gut microbiota functionality and barrier integrity, and gut-liver crosstalk in an
    Carbajo-Pescador S; Porras D; García-Mediavilla MV; Martínez-Flórez S; Juarez-Fernández M; Cuevas MJ; Mauriz JL; González-Gallego J; Nistal E; Sánchez-Campos S
    Dis Model Mech; 2019 Apr; 12(5):. PubMed ID: 30971408
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The chronic consumption of dietary fructose promotes the gut Clostridium species imbalance and bile acid alterations in developing nonalcoholic fatty liver disease.
    Zhang D; Wang H; Liu A; Wang S; Xu C; Lan K; Xiang W; Zhu K; Xiao Y; Fu J; Jiang R; Chen W; Ni Y
    J Nutr Biochem; 2023 Nov; 121():109434. PubMed ID: 37661068
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhanced offspring predisposition to steatohepatitis with maternal high-fat diet is associated with epigenetic and microbiome alterations.
    Wankhade UD; Zhong Y; Kang P; Alfaro M; Chintapalli SV; Thakali KM; Shankar K
    PLoS One; 2017; 12(4):e0175675. PubMed ID: 28414763
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Qiang-Gan formula extract improves non-alcoholic steatohepatitis via regulating bile acid metabolism and gut microbiota in mice.
    Li Q; Li M; Li F; Zhou W; Dang Y; Zhang L; Ji G
    J Ethnopharmacol; 2020 Aug; 258():112896. PubMed ID: 32325178
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Maternal high-fat diet regulates offspring hepatic ABCG5 expression and cholesterol metabolism via the gut microbiota and its derived butyrate.
    Zhang L; Zhang S; Zou W; Hu Y; Gao Y; Zhang J; Zheng J
    Clin Sci (Lond); 2024 Sep; 138(17):1039-1054. PubMed ID: 39136693
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Maternal Linoleic Acid Overconsumption Alters Offspring Gut and Adipose Tissue Homeostasis in Young but Not Older Adult Rats.
    Marchix J; Alain C; David-Le Gall S; Acuña-Amador LA; Druart C; Delzenne NM; Barloy-Hubler F; Legrand P; Boudry G
    Nutrients; 2020 Nov; 12(11):. PubMed ID: 33187208
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.
    Porras D; Nistal E; Martínez-Flórez S; Pisonero-Vaquero S; Olcoz JL; Jover R; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S
    Free Radic Biol Med; 2017 Jan; 102():188-202. PubMed ID: 27890642
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early life dietary emulsifier exposure predisposes the offspring to obesity through gut microbiota-FXR axis.
    Tang Q; Wang C; Jin G; Li Y; Hou H; Wang X; Guo Q; Liu T; Wang S; Dai X; Wang B; Cao H
    Food Res Int; 2022 Dec; 162(Pt A):111921. PubMed ID: 36461273
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A High-Fat, High-Cholesterol Diet Promotes Intestinal Inflammation by Exacerbating Gut Microbiome Dysbiosis and Bile Acid Disorders in Cholecystectomy.
    Xu F; Yu Z; Liu Y; Du T; Yu L; Tian F; Chen W; Zhai Q
    Nutrients; 2023 Sep; 15(17):. PubMed ID: 37686860
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Advanced liver steatosis accompanies an increase in hepatic inflammation, colonic, secondary bile acids and Lactobacillaceae/Lachnospiraceae bacteria in C57BL/6 mice fed a high-fat diet.
    Zeng H; Larson KJ; Cheng WH; Bukowski MR; Safratowich BD; Liu Z; Hakkak R
    J Nutr Biochem; 2020 Apr; 78():108336. PubMed ID: 32004929
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tectorigenin ameliorated high-fat diet-induced nonalcoholic fatty liver disease through anti-inflammation and modulating gut microbiota in mice.
    Duan R; Huang K; Guan X; Li S; Xia J; Shen M; Sun Z; Yu Z
    Food Chem Toxicol; 2022 Jun; 164():112948. PubMed ID: 35390440
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disease-Associated Gut Microbiota Reduces the Profile of Secondary Bile Acids in Pediatric Nonalcoholic Fatty Liver Disease.
    Yu J; Zhang H; Chen L; Ruan Y; Chen Y; Liu Q
    Front Cell Infect Microbiol; 2021; 11():698852. PubMed ID: 34568090
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.